Literature DB >> 21343587

The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression.

Björn K I Meijers, Pieter Evenepoel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21343587     DOI： 10.1093/ndt/gfq818

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  72 in total

Review 1.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

2.  Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Authors:  Tammy L Sirich; Benjamin A Funk; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

Review 3.  Kt/V (and especially its modifications) remains a useful measure of hemodialysis dose.

Authors:  John T Daugirdas
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

4.  Association of advanced age with concentrations of uraemic toxins in CKD.

Authors:  Merita Rroji; Sunny Eloot; Annemie Dhondt; Wim Van Biesen; Griet Glorieux; Nathalie Neirynck; Nele Vandennoortgate; Sophie Liabeuf; Ziad Massy; Raymond Vanholder
Journal:  J Nephrol       Date:  2015-04-10       Impact factor: 3.902

Review 5.  Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.

Authors:  Wei Pan; Yongbo Kang
Journal:  Int Urol Nephrol       Date:  2017-08-28       Impact factor: 2.370

6.  Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.

Authors:  Roberta T Salarolli; Livia Alvarenga; Ludmila F M F Cardozo; Karla T R Teixeira; Laís de S G Moreira; Jordana D Lima; Silvia D Rodrigues; Lia S Nakao; Denis Fouque; Denise Mafra
Journal:  Int Urol Nephrol       Date:  2021-01-12       Impact factor: 2.370

Review 7.  Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.

Authors:  Natalia Lucía Rukavina Mikusic; Nicolás Martín Kouyoumdzian; Marcelo Roberto Choi
Journal:  Pflugers Arch       Date:  2020-02-17       Impact factor: 3.657

Review 8.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

Review 9.  Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine.

Authors:  Chuan Zou; Zhao-Yu Lu; Yu-Chi Wu; Li-Hong Yang; Guo-Bin Su; Xi-Na Jie; Xu-Sheng Liu
Journal:  Chin J Integr Med       Date:  2013-01-31       Impact factor: 1.978

10.  Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.

Authors:  Megan Rossi; David W Johnson; Mark Morrison; Elaine M Pascoe; Jeff S Coombes; Josephine M Forbes; Cheuk-Chun Szeto; Brett C McWhinney; Jacobus P J Ungerer; Katrina L Campbell
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-15       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.